Search research articles
Contact Us
Filters
Showing results (61-70 of 150) with videos related to
Page
of 15
Sort By:
JAMA Oncology
|
September 19, 2024
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With <i>FGFR</i> RNA-Overexpressing Urothelial Cancer: The FORT-2 Phase 1b Nonrandomized Clinical Trial
Randy F Sweis, Pablo Gajate, Rafael Morales-Barrera, et al.
European Urology
|
June 24, 2022
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1
Fred Saad, Johann de Bono, Philippe Barthélémy, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
Immunotherapy
|
November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)
Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 2, 2024
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Alessandro Parisi, Marco Maruzzo, et al.
Immunotherapy
|
August 6, 2024
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study
Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, et al.
Clinical Genitourinary Cancer
|
January 19, 2016
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey
Alberto Diminutto, Umberto Basso, Marco Maruzzo, et al.
Therapeutic Advances in Medical Oncology
|
March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
November 19, 2018
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region
Marco Maruzzo, Umberto Basso, Eugenio Borsatti, et al.
Clinical Genitourinary Cancer
|
August 23, 2024
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney
Giulia Claire Giudice, Marco Maruzzo, Elena Verzoni, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 150) with videos related to
Sort By:
Page
of 15
JAMA Oncology
|
September 19, 2024
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With <i>FGFR</i> RNA-Overexpressing Urothelial Cancer: The FORT-2 Phase 1b Nonrandomized Clinical Trial
Randy F Sweis, Pablo Gajate, Rafael Morales-Barrera, et al.
European Urology
|
June 24, 2022
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1
Fred Saad, Johann de Bono, Philippe Barthélémy, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
Immunotherapy
|
November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)
Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 2, 2024
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Alessandro Parisi, Marco Maruzzo, et al.
Immunotherapy
|
August 6, 2024
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study
Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, et al.
Clinical Genitourinary Cancer
|
January 19, 2016
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey
Alberto Diminutto, Umberto Basso, Marco Maruzzo, et al.
Therapeutic Advances in Medical Oncology
|
March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
November 19, 2018
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region
Marco Maruzzo, Umberto Basso, Eugenio Borsatti, et al.
Clinical Genitourinary Cancer
|
August 23, 2024
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney
Giulia Claire Giudice, Marco Maruzzo, Elena Verzoni, et al.
Page
of 15